XML 45 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Note 23 - Income Taxes
12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
23.
INCOME TAXES
 
Cohen & Company Inc. is treated as a C corporation for United States federal income tax purposes. The components of income tax expense (benefit) included in the consolidated statements of operations for each year presented herein are shown in the table below.
 
INCOME TAX EXPENSE
(Dollars in Thousands)
 
   
For the Year Ended December 31,
 
   
2020
   
2019
   
2018
 
Current income tax expense (benefit)
                       
Federal income tax expense (benefit)   $
-
    $
(1
)   $
(29
)
Foreign income tax expense (benefit)    
122
     
156
     
26
 
State and local income tax expense (benefit)    
86
     
-
     
-
 
     
208
     
155
     
(3
)
Deferred income tax expense (benefit)
                       
Federal income tax expense (benefit)    
(7,430
)    
(324
)    
(722
)
Foreign income tax expense (benefit)    
-
     
-
     
-
 
State and local income tax expense (benefit)    
(1,447
)    
(354
)    
(116
)
     
(8,877
)    
(678
)    
(838
)
                         
Total
   
(8,669
)    
(523
)    
(841
)
 
The components of income (loss) before income taxes is shown below.
 
 
INCOME (LOSS) BEFORE INCOME TAXES
(Dollars in Thousands)
 
   
For the Year Ended December 31,
 
   
2020
   
2019
   
2018
 
Domestic   $
30,317
    $
(4,400
)   $
(3,864
)
Foreign    
(533
)    
304
     
(964
)
Total
  $
29,784
    $
(4,096
)   $
(4,828
)
 
The Company had
no
prepaid taxes in the consolidated balance sheet as of
December 31, 2020
and
2019,
respectively.
 
The expected income tax expense /(benefit) using the federal statutory rate differs from income tax expense / (benefit) pertaining to pre-tax income / (loss) as a result of the following for the years ended
December 31, 2020
,
2019
, and
2018
.  
 
 
INCOME TAX RATE RECONCILIATION
(Dollars in Thousands)
 
   
For the Year Ended December 31,
 
   
2020
   
2019
   
2018
 
Federal statutory rate   $
4,145
    $
(860
)   $
(1,014
)
Pass thru impact    
(2,945
)    
319
     
394
 
Deferred tax valuation allowance    
(10,183
)    
153
     
17
 
State and local tax    
192
     
(291
)    
(263
)
Foreign tax    
122
     
156
     
25
 
Total
  $
(8,669
)   $
(523
)   $
(841
)
 
Deferred tax assets and liabilities are determined based on the difference between the book basis and tax basis of assets and liabilities using tax rates in effect for the year in which the differences are expected to reverse. The recognition of deferred tax assets is reduced by a valuation allowance if it is more likely than
not
that the tax benefits will
not
be realized.
 
  
The components of the net deferred tax asset (liability) are as follows.
 
 
DEFERRED TAX ASSET AND LIABILITY
(Dollars in Thousands)
 
   
As of December 31, 2020
   
As of December 31, 2019
 
   
Asset
   
Liability
   
Net
   
Asset
   
Liability
   
Net
 
Federal net operating loss carry-forward   $
20,579
    $
-
    $
20,579
    $
21,508
    $
-
    $
21,508
 
State net operating loss carry-forward    
4,238
     
-
     
4,238
     
5,061
     
-
     
5,061
 
Federal capital loss carry-forward    
7,311
     
-
     
7,311
     
47,027
     
-
     
47,027
 
Unrealized gain on debt    
-
     
(5,670
)    
(5,670
)    
-
     
(7,911
)    
(7,911
)
Investment in Operating LLC    
14,402
     
-
     
14,402
     
24,569
     
-
     
24,569
 
Other    
312
     
-
     
312
     
2,525
     
-
     
2,525
 
Gross deferred tax asset / (liability)
   
46,842
     
(5,670
)    
41,172
     
100,690
     
(7,911
)    
92,779
 
Less: valuation allowance    
(33,775
)    
-
     
(33,775
)    
(94,118
)    
-
     
(94,118
)
Net deferred tax asset / (liability)
  $
13,067
    $
(5,670
)   $
7,397
    $
6,572
    $
(7,911
)   $
(1,339
)
 
As of
December 31, 2020
, the Company had a federal net operating loss (“NOL”) of approximately
$97,995,
which will be available to offset future taxable income, subject to limitations described below. If
not
used, this NOL will begin to expire in
2029.
The Company also had net capital losses (“NCLs”) in excess of capital gains of
$34,815
as of
December 31, 2020
, which can be carried forward to offset future capital gains, subject to the limitations described below. If
not
used, this carryforward will begin to expire in
2021.
No
assurance can be made that the Company will have future taxable income or future capital gains to benefit from its NOL and NCL carryovers.
 
The Company has determined that its NOL and NCL carryovers are
not
currently limited by Section 
382
of the Internal Revenue Code of
1986,
as amended (the “Code”). However, the Company
may
experience an ownership change as defined in that section (“Ownership Change”) in the future.
 
If an Ownership Change were to occur in the future, the Company's ability to use its NOLs, NCLs, and certain recognized built-in losses to reduce its taxable income in a future year would generally be limited to an annual amount (the “Section
382
Limitation”) equal to the fair value of the Company immediately prior to the Ownership Change multiplied by the “long term tax-exempt interest rate.” In the event of an Ownership Change, NOLs and NCLs that exceed the Section 
382
Limitation in any year will continue to be allowed as carryforwards for the remainder of the carryforward period, and such NOLs and NCLs can be used to offset taxable income for years within the carryforward period subject to the Section 
382
Limitation in each year. However, if the carryforward period for any NOL or NCL were to expire before that loss is fully utilized, the unused portion of that loss would be lost.  See discussion of stockholder rights plan in note
21.
 
Notwithstanding the facts that the Company has determined that the use of its remaining NOL and NCL carryforwards are
not
currently limited by Section 
382
of the Code, the Company recorded a valuation allowance for a substantial portion of its NOLs and NCLs when calculating its net deferred tax liability as of
December 31, 2020
. The valuation allowance was recorded because the Company determined it is
not
more likely than
not
that it will realize these benefits.
 
During
2020,
the Company recognized a significant deferred tax benefit.  The deferred tax benefit was a U.S. tax benefit, which was the result of the reduction in the valuation allowance applied against the Company's NOL and NCL tax assets.  Prior to
2020,
the Company had concluded that due to its recent history of tax losses, it should only recognize its NOL asset to the extent the reversal of its deferred tax liability amounts could be scheduled against it.  For the NCL tax asset, it applied a full valuation allowance.  In
2020,
the Company generated significant taxable income (both ordinary and capital) and expects to generate income going forward.  Accordingly, as of
December 31, 2020,
the Company adjusted the calculation of the valuation allowances applied against its NOL and NCL asset.  The Company now applies both the expected reversal of its deferred tax liability as well as an expected level of income based on
2020
actual results projected forward.  The recent improvement of the Company's operations was the result of income earned from the sponsorship of and investment in SPACs (mostly capital income) as well as improving operations of its other business lines (mostly operating income).  The Company will continue to reevaluate its operations on a quarterly basis and
may
make further adjustments to its tax valuation allowances going forward as is necessary.  These adjustments could be material and could result in additional tax benefit or tax expense.  These adjustments will only impact our deferred tax assets, liabilities, and expense or benefit.  The Company's current tax expense or benefit will
not
be impacted by these adjustments.  
 
The Company had
no
unrecognized tax benefits in the periods presented. 
 
The Company files tax returns in the U.S. federal jurisdiction, various states or local jurisdictions, the United Kingdom, Ireland, and France. With few exceptions, the Company is
no
longer subject to examination for years prior to
2015.